New York State Common Retirement Fund Has $187.45 Million Holdings in Intuitive Surgical, Inc. $ISRG

New York State Common Retirement Fund lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 419,138 shares of the medical equipment provider’s stock after selling 35,349 shares during the quarter. New York State Common Retirement Fund’s holdings in Intuitive Surgical were worth $187,451,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the business. SteelPeak Wealth LLC boosted its position in shares of Intuitive Surgical by 28.7% in the third quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock valued at $18,781,000 after acquiring an additional 9,364 shares during the period. Amalgamated Bank increased its position in Intuitive Surgical by 2.2% during the second quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock worth $44,311,000 after acquiring an additional 1,772 shares during the period. Bessemer Group Inc. raised its stake in Intuitive Surgical by 89.3% in the 2nd quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock worth $428,386,000 after purchasing an additional 371,806 shares in the last quarter. Sax Wealth Advisors LLC boosted its holdings in Intuitive Surgical by 218.1% in the 2nd quarter. Sax Wealth Advisors LLC now owns 2,456 shares of the medical equipment provider’s stock valued at $1,334,000 after purchasing an additional 1,684 shares during the period. Finally, World Investment Advisors boosted its holdings in Intuitive Surgical by 238.3% in the 3rd quarter. World Investment Advisors now owns 5,399 shares of the medical equipment provider’s stock valued at $2,415,000 after purchasing an additional 3,803 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $522.04 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $609.08. The stock’s fifty day moving average price is $560.68 and its two-hundred day moving average price is $511.75. The company has a market cap of $187.14 billion, a PE ratio of 66.16, a P/E/G ratio of 4.27 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. During the same period in the prior year, the company earned $2.21 EPS. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity

In related news, EVP Henry L. Charlton sold 13,731 shares of the company’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the transaction, the executive vice president directly owned 3,056 shares in the company, valued at $1,772,480. This represents a 81.80% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Fredrik Widman sold 2,067 shares of the firm’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $550.00, for a total transaction of $1,136,850.00. Following the completion of the sale, the vice president owned 473 shares in the company, valued at $260,150. This represents a 81.38% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 75,557 shares of company stock valued at $42,000,903. Corporate insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently weighed in on ISRG. Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Monday, December 29th. The Goldman Sachs Group restated a “buy” rating and set a $714.00 price objective on shares of Intuitive Surgical in a research note on Friday, January 9th. Argus lifted their price objective on Intuitive Surgical from $600.00 to $630.00 in a report on Monday, October 27th. BTIG Research reissued a “buy” rating and set a $616.00 target price on shares of Intuitive Surgical in a report on Friday, January 23rd. Finally, Zacks Research cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, January 21st. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $620.41.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: FDA cleared the da Vinci 5 system for select advanced cardiac procedures, expanding the platform’s addressable market in minimally invasive heart surgery; this strengthens the company’s procedure‑growth runway. Article Title
• Positive Sentiment: TD Cowen initiated coverage with a “strong‑buy” rating, adding a high‑profile research endorsement that can attract institutional and retail flows. Article Title
• Positive Sentiment: HSBC published a bullish forecast for strong price appreciation and Polen Capital highlighted ISRG as a core growth holding — signals of continued conviction from major sell‑side and active managers. Article Title
• Positive Sentiment: Recent quarterly results showed an EPS and revenue beat with ~19% YoY revenue growth, supporting the earnings‑growth outlook that underpins analyst price targets. Article Title
• Neutral Sentiment: A coverage piece asks whether it’s time to reassess ISRG after recent share‑price weakness — a helpful framing for valuation and momentum traders but not a direct corporate catalyst. Article Title
• Negative Sentiment: Large insider selling by director Gary S. Guthart (reports show 24,500 shares and an additional 2,800‑share sale at ~\$530) materially reduced his stake — a common near‑term negative for sentiment and a potential trigger for profit‑taking. Article Title
• Negative Sentiment: EVP Myriam Curet sold 230 shares (filed at ~\$532.61) — small on its own but adding to the day’s insider selling narrative. Article Title

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.